Clinical trials recruiting for Sodium-glucose Co-transporter-2 Inhibitors

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients
  NCT06398977 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease
  NCT07405216 · Phase: Phase 4 · Ages: 14 Years to 18 Years · Sex: All (male and female) · 1 location
• meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
  NCT05715814 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Sodium-glucose Co-transporter-2 Inhibitors often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Sodium-glucose Co-transporter-2 Inhibitors trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.